M.D.C. (MDC) Q3 2024 earnings summary

Executive summary

• Net income for Q3 2024 rose 24% year-over-year to $133.5 million, driven by strong financial services performance and a lower effective tax rate; nine-month net income was $254.5 million, down 10% from the prior year due to higher SG&A and merger-related costs.

• Home sale revenues increased 28% year-over-year in Q3 2024, with 2,539 homes delivered, while gross margin from home sales declined to 17.8% from 19.2% due to higher incentives and land costs.

• The company completed a $4.9 billion merger with SH Residential Holdings, LLC in April 2024, resulting in delisting from the NYSE and significant transaction and executive compensation expenses.

Financial highlights

• Q3 2024 home sale revenues: $1.39 billion (up 28% year-over-year); nine-month revenues: $4.12 billion (up 28%).

• Q3 2024 net income: $133.5 million (up 24% year-over-year); nine-month net income: $254.5 million (down 10%).

• Q3 2024 gross margin from home sales: 17.8% (down 140 bps year-over-year); nine-month gross margin: 17.8% (up 30 bps).

• Financial services pretax income for Q3 2024: $27.9 million (up 125% year-over-year); nine-month pretax income: $68.2 million (up 33%).

• Inventory impairments for Q3 2024: $6.3 million; nine-month impairments: $16.8 million (down from $27.5 million prior year).

Outlook and guidance

• Management expects to navigate market volatility with a strong balance sheet, $1.10 billion in cash and marketable securities, and no senior note maturities until 2030.

• Focus remains on building quick move-in inventory to meet demand and minimize cancellations, with a two- to three-year lot supply.